These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 1815976

  • 1. Salivation from the denervated human parotid gland induced by pirenzepine and telenzepine.
    Levin SL.
    Eur J Clin Pharmacol; 1991; 41(6):613-4. PubMed ID: 1815976
    [No Abstract] [Full Text] [Related]

  • 2. The effect of telenzepine and pirenzepine on salivation from the intact and denervated human parotid gland.
    Levin SL.
    Pharmacol Toxicol; 1991 Sep; 69(3):213-4. PubMed ID: 1796062
    [No Abstract] [Full Text] [Related]

  • 3. Salivatory effects induced by pirenzepine, atropine, metacine and hexamethonium in preganglionar chronically denervated human parotid gland.
    Levin SL, Kiselman IM.
    J Pharm Pharmacol; 1989 Dec; 41(12):868-71. PubMed ID: 2576453
    [Abstract] [Full Text] [Related]

  • 4. Salivatory responses to classical and nontraditional parasympatholytic agents in human subjects: critical comments.
    Levin SL.
    J Clin Pharmacol; 1992 Nov; 32(11):1013-22. PubMed ID: 1474162
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Domination of a strong antagonist over a weak one in paradoxical responses to cholinolytics in a parasympathetically denervated human salivary parotid gland: atropine and metacine as agonists, and chlorosyle as partial agonist.
    Levin SL.
    Gen Pharmacol; 1987 Nov; 18(5):569-74. PubMed ID: 3653678
    [Abstract] [Full Text] [Related]

  • 8. Salivatory effects induced by selective and non-selective cholinolytics in the chronically denervated human parotid gland.
    Levin SL.
    Br J Clin Pharmacol; 1991 Aug; 32(2):259. PubMed ID: 1931478
    [No Abstract] [Full Text] [Related]

  • 9. Telenzepine is at least 25 times more potent than pirenzepine--a dose response and comparative secretory study in man.
    Londong W, Londong V, Meierl A, Voderholzer U.
    Gut; 1987 Jul; 28(7):888-95. PubMed ID: 3653758
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gastric antisecretory activity of telenzepine, a new M1-selective muscarinic antagonist: comparison with pirenzepine.
    Coruzzi G, Adami M, Bertaccini G.
    Arch Int Pharmacodyn Ther; 1989 Jul; 302():232-41. PubMed ID: 2636819
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of selectivity of two different antimuscarinic substances.
    Engelhorn R.
    Scand J Gastroenterol Suppl; 1982 Jul; 72():49-58. PubMed ID: 6957997
    [No Abstract] [Full Text] [Related]

  • 14. The newer anticholinergic agents. II. Effectiveness as antisialogogues.
    ZUPKO AG, PROKOP LD.
    J Am Pharm Assoc Am Pharm Assoc; 1954 Apr; 43(4):219-21. PubMed ID: 13151982
    [No Abstract] [Full Text] [Related]

  • 15. The effect of the M1-selective telenzepine on esophageal acid exposure in healthy volunteers.
    Stockbrügger RW, Armbrecht U, Reul W.
    Z Gastroenterol; 1988 Jun; 26(6):297-302. PubMed ID: 3061181
    [Abstract] [Full Text] [Related]

  • 16. Telenzepine, a new M1-receptor antagonist, is a more potent inhibitor of pentagastrin-stimulated gastric acid output than pirenzepine in dogs.
    Holtmann G, Küppers U, Singer MV.
    Scand J Gastroenterol; 1990 Mar; 25(3):293-7. PubMed ID: 2320949
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of denervation on parotid gland function.
    Levin SL.
    Ann Otol Rhinol Laryngol; 1984 Mar; 93(2 Pt 1):176-8. PubMed ID: 6712090
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.